Earlier treatment with biologics to reduce the risk of organ damage in systemic lupus erythematosus (SLE)
Sponsored by GSK US Medical Affairs
Learn about the importance of reducing organ damage and corticosteroid-associated toxicity in SLE, and how biologics may help to change the course of
the disease by targeting its underlying mechanisms.